FDA actions in brief may 2012 Full Text
Formulary , 07/11/2012
Azelastine and fluticasone (Dymista, Meda) was approved for the treatment of seasonal allergic rhinitis. Insulin detemir [rDNA origin] injection (Levemir, Novo Nordisk) has expanded its pediatric indication and was approved for use for children aged 2 to 5 years old with type 1 diabetes. It is the first and only basal insulin analog approved for use in patients as young as age 2 years.